152.72
price down icon1.52%   -2.35
after-market アフターアワーズ: 152.72
loading
前日終値:
$155.07
開ける:
$154.05
24時間の取引高:
672.33K
Relative Volume:
0.69
時価総額:
$8.97B
収益:
$551.35M
当期純損益:
$-189.33M
株価収益率:
-46.40
EPS:
-3.2916
ネットキャッシュフロー:
$-35.09M
1週間 パフォーマンス:
+2.95%
1か月 パフォーマンス:
+24.68%
6か月 パフォーマンス:
+35.25%
1年 パフォーマンス:
+43.33%
1日の値動き範囲:
Value
$143.11
$156.60
1週間の範囲:
Value
$143.11
$156.60
52週間の値動き範囲:
Value
$73.16
$156.60

Glaukos Corp Stock (GKOS) Company Profile

Name
名前
Glaukos Corp
Name
セクター
Healthcare (1096)
Name
電話
949-367-9600
Name
住所
1 GLAUKOS WAY, ALISO VIEJO, CA
Name
職員
1,094
Name
Twitter
@GlaukosCorp
Name
次回の収益日
2026-07-29
Name
最新のSEC提出書
Name
GKOS's Discussions on Twitter

Compare GKOS vs ABT, SYK, MDT, BSX, EW

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
GKOS icon
GKOS
Glaukos Corp
152.72 8.97B 551.35M -189.33M -35.09M -3.2916
ABT icon
ABT
Abbott Laboratories
93.93 163.61B 45.13B 6.28B 7.38B 3.5895
SYK icon
SYK
Stryker Corp
329.78 126.42B 25.27B 3.34B 4.57B 8.6334
MDT icon
MDT
Medtronic Plc
83.87 107.36B 36.36B 4.84B 5.43B 3.7212
BSX icon
BSX
Boston Scientific Corp
44.77 66.54B 20.62B 3.56B 3.48B 2.3847
EW icon
EW
Edwards Lifesciences Corp
92.21 53.09B 6.30B 1.07B 1.09B 1.8406

Glaukos Corp Stock (GKOS) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-27 アップグレード Wells Fargo Equal Weight → Overweight
2025-10-01 開始されました Goldman Buy
2025-05-01 ダウングレード Wells Fargo Overweight → Equal Weight
2025-02-19 アップグレード Mizuho Neutral → Outperform
2024-12-11 アップグレード Citigroup Neutral → Buy
2024-12-06 開始されました UBS Buy
2024-12-02 ダウングレード Morgan Stanley Equal-Weight → Underweight
2024-07-10 ダウングレード Citigroup Buy → Neutral
2024-05-06 アップグレード Jefferies Hold → Buy
2023-12-21 アップグレード JP Morgan Neutral → Overweight
2023-12-04 開始されました Morgan Stanley Equal-Weight
2023-11-28 開始されました Truist Buy
2023-11-08 アップグレード Wells Fargo Equal Weight → Overweight
2023-06-07 アップグレード Piper Sandler Neutral → Overweight
2022-12-22 開始されました Mizuho Neutral
2022-12-19 アップグレード JP Morgan Underweight → Neutral
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-10-14 再開されました Stephens Overweight
2022-10-04 開始されました Needham Buy
2022-07-12 アップグレード Stifel Hold → Buy
2022-02-03 アップグレード William Blair Mkt Perform → Outperform
2022-01-19 アップグレード Wells Fargo Underweight → Equal Weight
2022-01-18 アップグレード BTIG Research Neutral → Buy
2021-11-03 アップグレード Stephens Equal-Weight → Overweight
2021-07-26 ダウングレード Stephens Overweight → Equal-Weight
2021-07-20 ダウングレード Wells Fargo Equal Weight → Underweight
2021-07-14 ダウングレード Oppenheimer Outperform → Perform
2021-07-14 ダウングレード William Blair Outperform → Mkt Perform
2021-04-08 アップグレード Oppenheimer Perform → Outperform
2021-01-29 ダウングレード Piper Sandler Overweight → Neutral
2020-12-16 アップグレード Citigroup Sell → Neutral
2020-12-09 開始されました Oppenheimer Perform
2020-11-17 アップグレード Wells Fargo Underweight → Equal Weight
2020-10-08 ダウングレード JP Morgan Neutral → Underweight
2020-06-15 開始されました Jefferies Hold
2020-03-05 開始されました Citigroup Sell
2020-02-28 ダウングレード JP Morgan Overweight → Neutral
2020-01-06 アップグレード Berenberg Hold → Buy
2019-12-12 ダウングレード Wells Fargo Outperform → Underperform
2019-09-30 ダウングレード BofA/Merrill Buy → Underperform
2019-03-08 開始されました BTIG Research Neutral
2018-08-30 開始されました Berenberg Hold
2018-08-29 アップグレード JP Morgan Neutral → Overweight
2018-08-03 繰り返されました Stifel Hold
2018-06-21 ダウングレード JP Morgan Overweight → Neutral
2018-04-13 ダウングレード Stifel Buy → Hold
2018-03-01 繰り返されました Cantor Fitzgerald Buy
2017-03-02 繰り返されました Cantor Fitzgerald Overweight
2017-01-06 アップグレード Stifel Hold → Buy
2016-10-27 開始されました Wells Fargo Outperform
すべてを表示

Glaukos Corp (GKOS) 最新ニュース

pulisher
Jul 10, 2026

Price to sales forward of Glaukos Corp – XETR:6GJ - TradingView

Jul 10, 2026
pulisher
Jul 09, 2026

Form 144 GLAUKOS Corp For: 9 July By Investing.com - Investing.com South Africa

Jul 09, 2026
pulisher
Jul 09, 2026

Form 144 GLAUKOS Corp For: 9 July - Investing.com UK

Jul 09, 2026
pulisher
Jul 09, 2026

Midday Stock Roundup: Alignment Healthcare Up 7.8% Ahead of Q2 Results - Orange County Business Journal

Jul 09, 2026
pulisher
Jul 09, 2026

Glaukos (GKOS) Form 144 shows 10,000-share sale, option exercise - Stock Titan

Jul 09, 2026
pulisher
Jul 08, 2026

Glaukos Corp CFO Alex Thurman sells $1.5m in shares - Investing.com

Jul 08, 2026
pulisher
Jul 08, 2026

Form 4 Glaukos Corp For: 8 July By Investing.com - Investing.com Nigeria

Jul 08, 2026
pulisher
Jul 08, 2026

Glaukos chief development officer Navratil sells $99,566 stock By Investing.com - Investing.com Nigeria

Jul 08, 2026
pulisher
Jul 08, 2026

Glaukos (GKOS) CFO executes pre-planned share sale and option exercise - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

Glaukos chief development officer Navratil sells $99,566 stock - Investing.com

Jul 08, 2026
pulisher
Jul 08, 2026

Glaukos (GKOS) chief development officer sells 716 shares under 10b5-1 plan - Stock Titan

Jul 08, 2026
pulisher
Jul 08, 2026

Abbott Labs vs. Glaukos: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Jul 08, 2026
pulisher
Jul 08, 2026

GKOS Maintained by Citigroup -- Price Target Raised to $175 - GuruFocus

Jul 08, 2026
pulisher
Jul 08, 2026

GKOS Stock Up More Than 45% Since May-End: What's Driving the Rally? - Yahoo Finance

Jul 08, 2026
pulisher
Jul 08, 2026

Glaukos to Release Second Quarter 2026 Financial Results after Market Close on July 29 - Business Wire

Jul 08, 2026
pulisher
Jul 07, 2026

Glaukos Corp stock and its role in eye disease treatment - ad-hoc-news.de

Jul 07, 2026
pulisher
Jul 06, 2026

Form 144 GLAUKOS Corp For: 6 July By Investing.com - Investing.com Nigeria

Jul 06, 2026
pulisher
Jul 06, 2026

Glaukos (NYSE: GKOS) files Form 144 to sell 10,000 shares - Stock Titan

Jul 06, 2026
pulisher
Jul 06, 2026

Glaukos stock rating reiterated at Outperform by William Blair - Investing.com

Jul 06, 2026
pulisher
Jul 02, 2026

Glaukos Rises as Reimbursement Milestone and Recent Pipeline Updates Support Sentiment - Quiver Quantitative

Jul 02, 2026
pulisher
Jul 02, 2026

Glaukos stock hits 52-week high at 148.12 USD By Investing.com - Investing.com Nigeria

Jul 02, 2026
pulisher
Jul 02, 2026

Glaukos stock hits 52-week high at 148.12 USD - Investing.com

Jul 02, 2026
pulisher
Jul 01, 2026

Form 144 GLAUKOS Corp For: 1 July - Investing.com UK

Jul 01, 2026
pulisher
Jul 01, 2026

Form 144 GLAUKOS Corp For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026
pulisher
Jul 01, 2026

GKOS (GKOS) insider sells 3,630 shares total across April and June 2026 - Stock Titan

Jul 01, 2026
pulisher
Jul 01, 2026

GKOS Reiterated by Piper Sandler -- Price Target Maintained at $165 - GuruFocus

Jul 01, 2026
pulisher
Jul 01, 2026

Piper Sandler reiterates Glaukos stock rating on iDose headwinds By Investing.com - Investing.com Nigeria

Jul 01, 2026
pulisher
Jul 01, 2026

Piper Sandler reiterates Glaukos stock rating on iDose headwinds - Investing.com

Jul 01, 2026
pulisher
Jun 29, 2026

Form 4 Glaukos Corp For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026
pulisher
Jun 29, 2026

Glaukos (NYSE: GKOS) CEO updates trust holdings, uses shares for tax withholding - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Form 4 Glaukos Corp For: 29 June - Investing.com UK

Jun 29, 2026
pulisher
Jun 29, 2026

Glaukos (NYSE: GKOS) president has 1,056 shares withheld for taxes - Stock Titan

Jun 29, 2026
pulisher
Jun 29, 2026

Glaukos (GKOS) CDO reports 483-share tax withholding, holds 88,350 shares - Stock Titan

Jun 29, 2026
pulisher
Jun 27, 2026

Enterprise value to EBIT forward of Glaukos Corp – XETR:6GJ - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

Price to book forward of Glaukos Corp – XETR:6GJ - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Enterprise value to EBITDA forward of Glaukos Corp – XETR:6GJ - TradingView

Jun 26, 2026
pulisher
Jun 25, 2026

Goldman Sachs Small Cap Equity Insights Fund's Glaukos Corp(GKOS) Holding History - GuruFocus

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos Corp Actuals & Estimates (NYSE:GKOS) - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos Moves Into Demodex Blepharitis Space - Orange County Business Journal

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos completes enrollment in phase 2 blepharitis study - Investing.com

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos Announces Completion of Patient Enrollment in Phase 2 Study of GLK-321 for Demodex Blepharitis - BioSpace

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos completes enrollment in phase 2 blepharitis study By Investing.com - Investing.com Australia

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos (GKOS) Completes Patient Enrollment in GLK-321 Study - GuruFocus

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos fills 275-patient trial of eyelid-disease drug candidate - Stock Titan

Jun 25, 2026
pulisher
Jun 25, 2026

Glaukos Corp (GKOS) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 25, 2026
pulisher
Jun 23, 2026

Form 4 Glaukos Corp For: 23 June By Investing.com - Investing.com Nigeria

Jun 23, 2026
pulisher
Jun 23, 2026

Form 4 Glaukos Corp For: 23 June - Investing.com UK

Jun 23, 2026
pulisher
Jun 23, 2026

Glaukos (NYSE: GKOS) director updates stock option grant to $106.52 strike - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

Glaukos (NYSE: GKOS) director Leana Wen awarded 2,987 stock options at $106.52 - Stock Titan

Jun 23, 2026
pulisher
Jun 23, 2026

GLAUKOS (GKOS) director Stapley gets 2,987 options at corrected $106.52 strike - Stock Titan

Jun 23, 2026

Glaukos Corp (GKOS) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
ZBH ZBH
$91.34
price up icon 2.36%
STE STE
$216.00
price up icon 0.00%
PHG PHG
$27.40
price up icon 0.51%
$74.96
price up icon 2.66%
$64.70
price up icon 0.00%
EW EW
$92.21
price up icon 0.96%
大文字化:     |  ボリューム (24 時間):